Magnesium/Lithium Preparations for Neuroprotection and Neurotrophic Benefits
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,229,667 | Magnesium/Lithium Preparations for Neuroprotection and Neurotrophic Benefits In force (reinstated) · Medium confidence UsedRemaining | FP Nutraceuticals, LLC | In force (reinstated) | Medium confidence | ||
| Application 16/128,349 | Saccharide-Based Oral Mucoadhesive Delivery System for Neurotrophic and Neuroprotective Compositions Abandoned Abandoned Dec 30, 2023 | FP Nutraceuticals, LLC | Abandoned | Abandoned Dec 30, 2023 | ||
| Application 16/673,038 | Saccharide-Based Oral Mucoadhesive Delivery System for Nutritional and Nutraceutical Compositions Abandoned Abandoned Sep 23, 2023 | FP Nutraceuticals, LLC | Abandoned | Abandoned Sep 23, 2023 | ||
| Application 16/673,125 | Hemp Oil / Magnesium Preparation for Cognitive-Enhancement and Reduction of Stress and Inflammation Abandoned Abandoned Aug 15, 2023 | FP Nutraceuticals, LLC | Abandoned | Abandoned Aug 15, 2023 | ||
| Application 16/996,889 | Compositions for Oral Mucoadhesive Dosage Forms Abandoned Abandoned Feb 14, 2024 | FP Nutraceuticals, LLC | Abandoned | Abandoned Feb 14, 2024 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by FP Neutraceuticals, LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.